Heart Disease News and Research

Latest Heart Disease News and Research

Comprehensive cardiac health study provides superior results

Kenneth "Buddy" Conant hit some clothing stores for a little shopping spree recently, but it wasn't because he'd suddenly become enthralled with the latest fashions. The truth was, he was starting to resemble a kid wearing a grown man's clothes.

6 Apr 2010

Antiarrhythmic drug dronedarone less effective and causes fewer side effects

In a rigorous new review of the antiarrhythmic drug dronedarone (Multaq), researchers at the Cedars-Sinai Heart Institute conclude that the controversial drug is only modestly effective and has no clear safety benefits.

6 Apr 2010

KHN column: Why Americans should support an individual mandate

In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.

6 Apr 2010

People with depression and anxiety disorders can benefit from exercise program

Exercise is a magic drug for many people with depression and anxiety disorders, and it should be more widely prescribed by mental health care providers, according to researchers who analyzed the results of numerous published studies.

6 Apr 2010

TachoSil blood-clotting patch receives FDA approval for cardiovascular surgery

The U.S. Food and Drug Administration today approved TachoSil, the first absorbable fibrin sealant patch for use in cardiovascular surgery to prevent mild and moderate bleeding from small blood vessels, when standard surgical techniques are ineffective or impractical.

6 Apr 2010

Humana adopts radiology benefit management programs to reduce unnecessary radiation exposure

Humana Inc. has reduced unnecessary radiation exposure for its members by the equivalent of more than five million chest x-rays since 2004, demonstrating how health benefits companies can lead the way in improving the quality and safety of health.

6 Apr 2010

FDA-approved contrast agent improves optical imaging of stem cells

A study published in the current issue of Cell Transplantation (19:1) has found that using the FDA-approved contrast agent Indocyanine Green (ICG) to label human embryonic stem cell-derived cardiomyocytes (hESC-CMs) substantially improved efforts to optically track stem cells after transplanting them into heart tissues.

6 Apr 2010

Older riders more likely to die from motorcycle accidents

Motorcycle riders across the country are growing older, and the impact of this trend is evident in emergency rooms daily. Doctors are finding that these aging road warriors are more likely to be injured or die as a result of a motorcycle mishap compared to their younger counterparts.

6 Apr 2010

Rice University's nano-bio-chip 93% specific in detecting patients with premalignant lesions

The gentle touch of a lesion on the tongue or cheek with a brush can help detect oral cancer with success rates comparable to more invasive techniques, according to preliminary studies by researchers at Rice University, the University of Texas Health Science Centers at Houston and San Antonio and the University of Texas M.D. Anderson Cancer Center.

6 Apr 2010

Menstrual stem cells may help in treatment of stroke and central nervous system disorders

Cryo-Cell International, Inc. today announced results of a study published this month in the cover article of Stem Cells and Development showing that stem cells found in menstrual blood may one day be a potential source for stem cell therapies in stroke and other central nervous system disorders.

5 Apr 2010

Children's Hospitals and Clinics of Minnesota announces opening of new Cardiovascular Center

Children's Hospitals and Clinics of Minnesota is opening a new world-class Cardiovascular Center—the only one of its kind in the Upper Midwest—that integrates all pediatric cardiac services in one location. The new Cardiovascular Center reflects Children's dedication to family-centered care with all private patient rooms with the latest in technology for both the patient and care team, a state-of-the-art hybrid operating room, and 24/7 access to specially trained cardiac intensivists to ensure the best possible care for patients.

5 Apr 2010

Juventas Therapeutics commences enrollment in Phase I trial of JVS-100 for treatment of Class III heart failure

Juventas Therapeutics, a privately held, clinical-stage regenerative medicine company announced it has started enrolling patients in a Phase I clinical trial for JVS-100 to evaluate safety and efficacy in the treatment of patients with Class III heart failure. JVS-100 encodes Stromal Cell-derived Factor-1 (SDF-1) and has been shown in pre-clinical studies to significantly increase cardiac function by promoting cell survival and increasing new blood vessel formation in the damaged organ.

5 Apr 2010

First Edition: April 5, 2010

Both the politics and policies of health reform continue to grab headlines, with reports highlighting how lawmakers are faring in their districts during this congressional recess. News outlets also are exploring how specific provisions of the new law will work.

5 Apr 2010

Rebirth of the cursed drug Thalidomide

Thalidomide was once a dreaded name in the Pharmaceutical industry. It was initially marketed in some European countries nearly 5 decades back as a sedative and after millions of pregnant women took it for morning sickness it had devastating results on the babies. The babies were born with flippers instead of limbs a condition known as phocomelia. Since then it has been under strict control.

5 Apr 2010

Are Australians popping too many pills?

These reports have emerged from a Daily Telegraph investigation. Australian Medical Association vice president, GP and former Pharmaceutical Benefits Advisory Committee member Dr Steve Hambleton said the resons for these trends may include the increasing population of the aged, newer medicines as well as a rise in chronic lifestyle ailments like diabetes and high blood pressure.

5 Apr 2010

Why is the genome project not yielding results faster?

As the genome projects reaches the 10 year landmark scientists are defending it. While the sequencing of the 3 billion letters in the human DNA took a long time the first draft of the human genome was presented ten years ago. Today it is possible to have your individual DNA mapped in a day and at the low cost of $5,000.

5 Apr 2010

Desert Valley Hospital, Montclair Hospital Medical Center named winners of Top 100 Hospitals

Thomson Reuters announced today that Desert Valley Hospital and Montclair Hospital Medical Center are among the winners of its prestigious Top 100 Hospitals® in the Nation award. Desert Valley Hospital, Victorville, CA, is now among an elite group of hospitals who have received this award five times in the category of small community hospitals. Montclair Hospital Medical Center, Montclair, CA. received the award for the first time in the class of medium size community hospitals.

5 Apr 2010

New report assesses optimal future for REMS

Two years after the Food and Drug Administration Amendments Act of 2007 gave FDA new powers to require Risk Evaluation and Mitigation Strategies for higher risk drugs and biologics, a new report concludes that an optimal future for REMS is possible if the agency adopts a systems approach when designing REMS programs and takes advantage of new technologies -- from electronic medical records to genetic testing -- that are changing the way medicine is practiced.

5 Apr 2010

U.S. Census Bureau highlights vitamin C

Today, we should raise a toast of orange juice to Dr. C.C. King of the University of Pittsburgh. It was on this day in 1932 that he isolated vitamin C.

5 Apr 2010

SRI director on importance of seeking treatment for sex addiction

Following rumours that Jesse James has checked into rehab for sex addiction, Robert Weiss, LCSW, CSAT-S, founding director of the Sexual Recovery Institute, today issued the following statement to explain how simple pleasure oriented behaviours can evolve into addiction and the importance of seeking treatment.

3 Apr 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Comprehensive cardiac health study provides superior results

Antiarrhythmic drug dronedarone less effective and causes fewer side effects

KHN column: Why Americans should support an individual mandate

People with depression and anxiety disorders can benefit from exercise program

TachoSil blood-clotting patch receives FDA approval for cardiovascular surgery

Humana adopts radiology benefit management programs to reduce unnecessary radiation exposure

FDA-approved contrast agent improves optical imaging of stem cells

Older riders more likely to die from motorcycle accidents

Rice University's nano-bio-chip 93% specific in detecting patients with premalignant lesions

Menstrual stem cells may help in treatment of stroke and central nervous system disorders

Children's Hospitals and Clinics of Minnesota announces opening of new Cardiovascular Center

Juventas Therapeutics commences enrollment in Phase I trial of JVS-100 for treatment of Class III heart failure

First Edition: April 5, 2010

Rebirth of the cursed drug Thalidomide

Are Australians popping too many pills?

Why is the genome project not yielding results faster?

Desert Valley Hospital, Montclair Hospital Medical Center named winners of Top 100 Hospitals

New report assesses optimal future for REMS

U.S. Census Bureau highlights vitamin C

SRI director on importance of seeking treatment for sex addiction

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in